Objective. To describe the efficiency of HMOs and to test the robustness of
these findings across alternative models of efficiency. This study examine
s whether these models, when constructed in parallel to use the same inform
ation, provide researchers with the same insights and identify the same tre
nds.
Data Sources. A data set containing 585 HMOs operating from 1985 through 19
94. Variables include enrollment, utilization, and financial information co
mpiled primarily from Health Care Investment Analysts, InterStudy HMO Censu
s, and Group Health Association of America.
Study Design. We compute three estimates of efficiency for each HMO and com
pare the results in terms of individual performance and industry-wide trend
s. The estimates are then regressed against measures of case mix, quality,
and other factors that may be related to the model estimates.
Principal Findings. The three models identify similar trends for the HMO in
dustry as a whole; however, they assess the relative technical efficiency o
f individual firms differently. Thus, these techniques are limited for eith
er benchmarking or setting rates because the firms identified as efficient
may be a consequence of model selection rather than actual performance.
Conclusions. The estimation technique to evaluate efficient firms can affec
t the findings themselves. The implications are relevant not only for HMOs,
but for efficiency analyses in general. Concurrence among techniques is no
guarantee of accuracy, but it is reassuring; conversely, radically distinc
t inferences across models can be a warning to temper research conclusions.